Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:867-874

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chansel, D.
Right arrow Articles by Ardaillou, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chansel, D.
Right arrow Articles by Ardaillou, R.

(Hypertension. 1996;27:867-874.)
© 1996 American Heart Association, Inc.


Articles

Regulation of Angiotensin II Receptor Subtypes by Dexamethasone in Rat Mesangial Cells

Dominique Chansel; Catherine Llorens-Cortes; Sophie Vandermeersch; Paul Pham; Raymond Ardaillou

From INSERM 64, Hôpital Tenon (D.C., S.V., R.A.); INSERM 36, Collège de France (C.L.-C.), Paris; and Centre d'Etudes Nucleaires Saclay, Gif-sur-Yvette (P.P.), France.

Correspondence to Raymond Ardaillou, Hôpital Tenon, 4 Rue de la Chine, 75020 Paris, France.

Abstract The objective of this study was to examine the role of dexamethasone on the expression of angiotensin II (Ang II) receptors in cultured rat mesangial cells. Dexamethasone caused concentration- and time-dependent decreases in 125I–[Sar1,Ala8]Ang II binding that were prevented by glucocorticoid receptor inhibition with mifepristone. A lag time of 24 hours and a dexamethasone concentration of at least 10 nmol/L were necessary for this effect to occur. Dexamethasone-induced reduction of 125I–[Sar1,Ala8]Ang II binding resulted from decreased Ang II type 1 (AT1) receptor density. No change in the apparent dissociation constant was observed. Dexamethasone also markedly inhibited Ang II–dependent inositol phosphate accumulation. Both reverse transcription–polymerase chain reaction and Northern blot analysis using specific short probes from the 3' noncoding region of the cDNA demonstrated the presence of AT1A and AT1B receptor mRNAs in rat mesangial cells, with a slight predominance of AT1B. Therefore, we studied the effect of dexamethasone on the expression of these two subtypes in rat mesangial cells. Dexamethasone produced a time-dependent decrease of AT1B receptor mRNA that was apparent after 6 hours of incubation, whereas AT1A receptor mRNA did not change. Mifepristone also suppressed the dexamethasone-induced decrease in AT1B receptor mRNA. In conclusion, glucocorticoids diminish Ang II receptor density at the mesangial cell surface through a mechanism that implies successive interaction with the glucocorticoid receptor and specific reduction in AT1B receptor mRNA expression. This differential regulation of both AT1 receptor subtypes might allow glucocorticoids to exert adjusted effects in their various target tissues.


Key Words: receptors, angiotensin II • rat • mesangial cells • dexamethasone • mifepristone




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
I. G Bogdarina, P. J King, and A. J L Clark
Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids
J. Mol. Endocrinol., August 1, 2009; 43(2): 73 - 80.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. R. Singh, K. M. Moritz, J. F. Bertram, and L. A. Cullen-McEwen
Effects of dexamethasone exposure on rat metanephric development: in vitro and in vivo studies
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F548 - F554.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Y. Park, C. Y. Song, B. C. Kim, H. K. Hong, and H. S. Lee
Angiotensin II mediates LDL-induced superoxide generation in mesangial cells
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F909 - F915.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Hus-Citharel, N. Bouby, J. Marchetti, D. Chansel, D. Goidin, D. Gourdji, P. Corvol, and C. Llorens-Cortes
Desensitization of Type 1 Angiotensin II Receptor Subtypes in the Rat Kidney
Endocrinology, November 1, 2001; 142(11): 4683 - 4692.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C.-B. Lanz, M. Causevic, C. Heiniger, F. J. Frey, B. M. Frey, and M. G. Mohaupt
Fluid Shear Stress Reduces 11{beta}-Hydroxysteroid Dehydrogenase Type 2
Hypertension, January 1, 2001; 37(1): 160 - 169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Schwobel, T. Fischer, B. Lanz, and M. Mohaupt
Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells
Am J Physiol Renal Physiol, December 1, 2000; 279(6): F1092 - F1100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Amiri and R. Garcia
Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells
Am J Physiol Renal Physiol, May 1, 1999; 276(5): F691 - F699.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Zhu, S. H. Zhang, C. Wagner, A. Kurtz, N. Maeda, T. Coffman, and W. J. Arendshorst
Angiotensin AT1B Receptor Mediates Calcium Signaling in Vascular Smooth Muscle Cells of AT1A Receptor–Deficient Mice
Hypertension, May 1, 1998; 31(5): 1171 - 1177.
[Abstract] [Full Text] [PDF]